Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7347 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Daily physical activity, even at light intensities, linked to lower cancer risk

A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.

One-third of antibiotics used in Vietnam are ‘inappropriate’

Ranking 11th globally in antibiotic use, Vietnam faces a serious risk of drug resistance, and could be ‘running out of treatment options due to antibiotic resistance’.

Digital test is a boost to READ-OUT biomarker study into effective ways of spotting dementia sooner

People could get the right help for the diseases that can cause dementia sooner following the announcement today of a £2 million injection of funding from the government to help spot these earlier.

Informing policy on AI in brain science and mental health

Two researchers in the Department of Psychiatry contributed to key government reports on mental health for MPs and other policy makers.

New study reveals details of key immune mechanism

An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.

New project tackles the 'undruggable' in acute leukaemia treatment

University of Oxford researcher, Katherine Vallis, has been awarded new funding from the MRC to launch a project on the use of cell-permeant antibodies for the treatment of acute leukaemia. The funding will allow Prof. Vallis and her team to generate in vivo data on the use of cell-penetrating peptides (CPPs) for cancer applications, a crucial step towards clinical translation.

Oxford marks World Tuberculosis Day as vaccine trials continue

Monday 24 March is World Tuberculosis Day. Along with its international collaborators, Oxford remains at the forefront of research to develop new vaccines to protect against this devastating disease.

New biopsy technique found to improve prostate cancer detection

Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.

Ancient genomic linkage regulates red blood cell development

A collaboration between the Drakesmith and Higgs Groups at the Medical Research Council Weatherall Institute of Molecular Medicine (MRC WIMM) has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.

Research shows importance of genomic testing and targeted therapies for advanced cancers

Genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%, according to researchers at the Norfolk and Norwich University Hospital, University of Adelaide and University of Oxford.

RECOVERY trial team win National Institute of Health and Care Research (NIHR) Impact Prize

Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact”.

Professor Michael Kidd appointed as Australia's next Chief Medical Officer

Professor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.

World Happiness Report 2025 shows people are much kinder than we expect

Belief in the kindness of others is much more closely tied to happiness than previously thought, according to World Happiness Report 2025, published by the Wellbeing Research Centre at the University of Oxford.

Research about whiplash published in two new papers

The findings come from the Neuromusculoskeletal Health and Science Lab’s whiplash cohort.

Balancing Reward with Threat Highlights the Interplay between Brain, Behaviour, and Individual Traits

Daily life involves a continuous balance between pursuing positive opportunities – rewards – and remaining vigilant to threats, a dynamic process that is critical for survival in both humans and animals.

Prioritising research to better address high-consequence outbreaks

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

Sixty Seconds with Kay Penicud

In this Sixty Seconds interview, Kay Penicud, Vice President and Head of Research Partnerships at Apollo Therapeutics, shares how Apollo’s collaboration with the University of Oxford offers researchers the support they need to bring their discoveries to patients more quickly, improving access to drug development expertise and driving real impact in healthcare. Kay also reflects on her own journey, starting as a Biochemist at Brasenose College, and how returning to Oxford through this partnership has been a full-circle moment in her career.

Oxford tops QS World University Rankings in English, physiology and geography

The University of Oxford has secured the top place in the QS World University Rankings 2025 in three subjects: English Language and Literature, Physiology and Geography.

Study supports future research into proteins by comparing different technologies

The results of this study will help researchers when considering which assays to use in future proteomics studies, and how to interpret their results. The study is published in Nature Communications.

New Cragg lab paper published in Nature Neuroscience - Acetylcholine and dopamine: friends or foes?

In a recent study published in Nature Neuroscience, work led by Dr Yanfeng Zhang, a former postdoctoral researcher in the Cragg lab now a lecturer at the University of Exeter, and Professor Stephanie Cragg, revealed that cholinergic interneurons in the striatum operate a dynamic, ongoing scaling depression of striatal dopamine release.

Load More